HCV Genotyping
The actual product may vary from the images shown on the website.
During diagnosis of blood-borne infections, PCR technology has a great importance especially in blood banking and to detection very early infections before antibodies have been developed.
PCR technology solves the following blood banking tasks:
• Ensuring infection safety during the period of “seronegative window”;
• Providing information that no infectious agents were found in the blood or blood components with ambiguous results of enzyme multiplied immunoassay obtained;
• Identifying true virus carriers among seropositive individuals.
With PCR it is possible to detect the RNA of hepatitis C virus not only in blood serum but also in liver biopsy specimens, which is important in confirming the role of hepatitis C virus in the formation of hepatocellular carcinoma. In such patients, hepatitis C virus RNA is detected in hepatocytes and in the absence of anti-HCV and HCV RNA in blood serum. Anti-HCV does not appear at all among a number of patients with self-limited course of infection.
The HCV Real-time PCR genotyping Kit is intended for detection of Hepatitis C virus and its genotyping in samples of peripheral blood plasma by real-time PCR method.
The kit can be used for in vitro diagnostics of 1a, 1b, 2 and 3a/3b.
Certification: RU/IVD
| Sample | Peripheral blood plasma |
| NA extraction | PREP-NA |
| Sensitivity | 200 copies per 1.0 mL of blood plasma |
| Time of analysis | 5 hours (including sample preparation procedure) |
| Storage requirements | +2...+8° С |
| Except of minus part of the kit | -18 … -22° С |
| Shelf life | 9 month |
|
Detection instruments |
Number of tests |
Tubes(ml)/ Strips |
Product number |
|
The kit is compatible with DT instruments (DNA-Technology); iQ5 iCycler (Bio-Rad) with 2 or more detection channels |
48 |
0.2 |
R4-P604-23/4EU |
|
0.2х8 |
R4-P604-S3/4EU |
